BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ), Finward Bancorp (Nasdaq – FNWD)GlobeNewsWire · 3 days ago
Cencora to acquire American Oncology Network in $2.4 billion dealReuters · 3 days ago
Cencora to Acquire American Oncology Network to Strengthen Support of Community OncologyBusiness Wire · 3 days ago
IFP Advisors Inc Purchases 14,078 Shares of Cencora, Inc. $CORDefense World · 6 days ago
Cencora, Inc. $COR Stake Increased by Frank Rimerman Advisors LLCDefense World · 6 days ago
Cencora (NYSE:COR) and Option Care Health (NASDAQ:OPCH) Financial ContrastDefense World · Oct 17, 2026Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | $4.35 | $4.48 | Beat |
| May 6, 2026 | $4.82 | $4.75 | Miss |
| Feb 4, 2026 | $4.05 | $4.08 | Beat |
| Nov 5, 2025 | $3.79 | $3.84 | Beat |
| Aug 6, 2025 | $3.85 | $4.00 | Beat |
| May 7, 2025 | $4.11 | $4.42 | Beat |